Scholars@ODU
Scholars@odu
Browse
Browse
Home
People
Organizations
Research
Events
Capability Map
FAQ
R. Freedman
Visualizations
Co-author Network
Map of Science
R. Freedman
Publications
Publications
Selected Publications
Articles In Academic Journals
Filter
Year
Title
2005
Identification of HLA-DQalpha and -DRbeta residues associated with susceptibility and protection to epithelial ovarian cancer
.
Human Immunology
. 554-562.
2003
Immune responses to human tumors: Development of tumor vaccines
.
Anticancer Research
. 1969-1996.
2002
Phase I study of intraperitoneal rh-IL-12 in patients with Mullerian, Gastrointenstinal Primary Malignancies and Mesothelioma
.
Clinical Cancer Research
. 3686-3695.
2000
Clinical and biological effects of intraperitoneal injections of recombinant IFN-alpha and recombinant IL-2 with or without tumor infiltrating lymphocytes in patients with ovarian or peritoneal carcinoma
.
Clinical Cancer Research
. 2268-2278.
2000
Expression of costimulatory molecules CD80 and CD86 and their receptors on tumor infiltrating lymphocytes from patients with ovarian carcinoma and other peritoneal carcinomatosis
.
Clinical and Experimental Immunology
. 19-27.
1999
Identification of an IL-10-producing, HLA-DR-negative, monocyte subset in the malignant ascites of patients with ovarian carcinoma, which inhibits cytokine protein expression and proliferation of autologous T cells
.
Journal of Immunology
. 6251-6260.
1999
Quantitative analysis of transforming growth factor-beta (TGF-?) and HLA class I and II in epithelial ovarian cancer
.
Clinical Cancer Research
. 2498-2505.
1998
Differential expression of cytokine transcripts in human epithelial ovarian carcinoma by solid tumour specimens, peritoneal exudate cells containing tumour, tumour-infiltrating lymphocyte (TIL)-derived T-cell lines and established tumour cell lines
.
Clinical and Experimental Immunology
. 172-180.
1998
Intraperitoneal immunotherapy of peritoneal carcinomatosis. Cytokines.
.
Cellular and Molecular Therapy
. 121-140.
1998
Lineage-negative human leukocyte antigen-DR+ cells with the phenotype of undifferentiated dendritic cells in patients with carcinoma of the abdomen and pelvis
.
Clinical Cancer Research
. 799-809.
1998
Reverse transcription-PCR quantitation of cytokine responses in vivo from specimens containing small numbers of cells during immunotherapy
.
Journal of Immunological Methods
. 169-179.
1996
HLA class I expression on human ovarian carcinoma cells correlates with T-cell infiltration in vivo and T-cell expansion in vitro in low concentrations of recombinant interleukin-2
.
Cellular Immunology
. 116-128.
1996
Immunopharmacology and cytokine production of a low dose schedule of intraperitoneally administered human recombinant interleukin-2 in patients with advanced epithelial ovarian carcinoma
.
Journal of Immunotherapy
. 443-451.
1996
Use of a retroviral vector to study the trafficking patterns of purified ovarian tumor-infiltrating lymphocytes (TIL) used in intraperitoneal adoptive immunotherapy of ovarian cancer patients - A pilot study
.
Human Gene Therapy
. 1351-1365.
Chapters
Filter
Year
Title
1998
Progress toward tumor-specific immunity in carcinomas of the ovary and breast
.
Cancer in Women
. Oxford, London, Berlin, Tokyo: Blackwell Science Publication.